(1->4)-beta-D-glucan multiple interactions ISO RGD:68563 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SLC7A2 mRNA CTD PMID:36331819 17alpha-ethynylestradiol multiple interactions ISO RGD:68563 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC7A2 mRNA CTD PMID:17942748 17beta-estradiol multiple interactions ISO RGD:68562 6480464 [Progesterone co-treated with Estradiol] results in increased expression of SLC7A2 mRNA CTD PMID:17404688 17beta-estradiol increases expression ISO RGD:68562 6480464 Estradiol results in increased expression of SLC7A2 mRNA CTD PMID:19167446 , PMID:32387340 17beta-estradiol decreases expression ISO RGD:68562 6480464 Estradiol results in decreased expression of SLC7A2 mRNA CTD PMID:21185374 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:68563 6480464 [Tetrachlorodibenzodioxin affects the methylation of SLC7A2 intron] which results in decreased expression of SLC7A2 mRNA, [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC7A2 mRNA CTD PMID:17942748 , PMID:33017471 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:68563 6480464 Tetrachlorodibenzodioxin affects the expression of SLC7A2 mRNA CTD PMID:21570461 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC7A2 mRNA CTD PMID:21215274 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of SLC7A2 mRNA CTD PMID:22298810 , PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:68563 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC7A2 mRNA CTD PMID:19770486 , PMID:19933214 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 3,3',4,4'-tetrachlorobiphenyl multiple interactions ISO RGD:68563 6480464 3 more ... CTD PMID:19467301 3,3',5,5'-tetrabromobisphenol A decreases expression ISO RGD:68563 6480464 tetrabromobisphenol A results in decreased expression of SLC7A2 mRNA CTD PMID:25172293 3-Iodothyronamine affects uptake ISO RGD:68562 6480464 SLC7A2 mRNA affects the uptake of 3-iodothyronamine CTD PMID:19074582 4,4'-diaminodiphenylmethane increases expression ISO RGD:68563 6480464 4, 4'-diaminodiphenylmethane results in increased expression of SLC7A2 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol increases expression ISO RGD:68563 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of SLC7A2 mRNA CTD PMID:30951980 4-hydroxynon-2-enal decreases expression ISO RGD:68563 6480464 4-hydroxy-2-nonenal results in decreased expression of SLC7A2 mRNA CTD PMID:19191707 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of SLC7A2 mRNA CTD PMID:31881176 acrolein multiple interactions ISO RGD:68562 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of SLC7A2 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of SLC7A2 mRNA CTD PMID:32699268 aflatoxin B1 decreases expression ISO RGD:68563 6480464 Aflatoxin B1 results in decreased expression of SLC7A2 mRNA CTD PMID:19770486 aflatoxin B1 decreases methylation ISO RGD:68562 6480464 Aflatoxin B1 results in decreased methylation of SLC7A2 gene CTD PMID:27153756 aflatoxin B1 decreases expression ISO RGD:68562 6480464 Aflatoxin B1 results in decreased expression of SLC7A2 mRNA CTD PMID:27153756 aldrin decreases expression ISO RGD:68563 6480464 Aldrin results in decreased expression of SLC7A2 mRNA CTD PMID:18579281 all-trans-retinoic acid increases expression ISO RGD:68562 6480464 Tretinoin results in increased expression of SLC7A2 mRNA CTD PMID:21934132 all-trans-retinoic acid decreases expression ISO RGD:68562 6480464 Tretinoin results in decreased expression of SLC7A2 mRNA CTD PMID:15894607 , PMID:33167477 alpha-pinene multiple interactions ISO RGD:68562 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of SLC7A2 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of SLC7A2 mRNA CTD PMID:32699268 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of SLC7A2 mRNA CTD PMID:16483693 amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of SLC7A2 mRNA CTD PMID:30779732 aristolochic acid A decreases expression ISO RGD:68562 6480464 aristolochic acid I results in decreased expression of SLC7A2 mRNA CTD PMID:33212167 arsane multiple interactions ISO RGD:68563 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SLC7A2 mRNA CTD PMID:32045263 arsenic atom multiple interactions ISO RGD:68563 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SLC7A2 mRNA CTD PMID:32045263 arsenite(3-) decreases expression ISO RGD:68563 6480464 arsenite results in decreased expression of SLC7A2 mRNA CTD PMID:18929588 arsenite(3-) multiple interactions ISO RGD:68563 6480464 TRP53 protein affects the reaction [arsenite results in decreased expression of SLC7A2 mRNA] CTD PMID:18929588 benzo[a]pyrene decreases expression ISO RGD:68563 6480464 Benzo(a)pyrene results in decreased expression of SLC7A2 mRNA CTD PMID:19770486 benzo[a]pyrene increases methylation ISO RGD:68562 6480464 Benzo(a)pyrene results in increased methylation of SLC7A2 promoter CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:68562 6480464 Benzo(a)pyrene affects the methylation of SLC7A2 5' UTR CTD PMID:27901495 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of SLC7A2 mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:68563 6480464 bisphenol A results in decreased expression of SLC7A2 mRNA CTD PMID:32156529 bisphenol A increases expression ISO RGD:68562 6480464 bisphenol A analog results in increased expression of SLC7A2 mRNA, bisphenol A results in increased expression of SLC7A2 mRNA CTD PMID:32387340 bisphenol A increases expression ISO RGD:68563 6480464 bisphenol A results in increased expression of SLC7A2 mRNA CTD PMID:30951980 Bisphenol B increases expression ISO RGD:68562 6480464 bisphenol B results in increased expression of SLC7A2 mRNA CTD PMID:32387340 bisphenol F increases expression ISO RGD:68563 6480464 bisphenol F results in increased expression of SLC7A2 mRNA CTD PMID:30951980 calcitriol decreases expression ISO RGD:68562 6480464 Calcitriol results in decreased expression of SLC7A2 mRNA CTD PMID:21592394 calcitriol multiple interactions ISO RGD:68562 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of SLC7A2 mRNA CTD PMID:21592394 carbon nanotube increases expression ISO RGD:68563 6480464 Nanotubes, Carbon analog results in increased expression of SLC7A2 mRNA CTD PMID:25554681 CGP 52608 multiple interactions ISO RGD:68562 6480464 CGP 52608 promotes the reaction [RORA protein binds to SLC7A2 gene] CTD PMID:28238834 choline multiple interactions ISO RGD:68563 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of SLC7A2 mRNA CTD PMID:20938992 ciguatoxin CTX1B affects expression ISO RGD:68563 6480464 Ciguatoxins affects the expression of SLC7A2 mRNA CTD PMID:18353800 cisplatin decreases expression ISO RGD:68562 6480464 Cisplatin results in decreased expression of SLC7A2 mRNA CTD PMID:27594783 clofibrate multiple interactions ISO RGD:68563 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of SLC7A2 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of SLC7A2 mRNA] CTD PMID:17585979 clofibrate decreases expression ISO RGD:68563 6480464 Clofibrate results in decreased expression of SLC7A2 mRNA CTD PMID:17585979 clofibric acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of SLC7A2 mRNA CTD PMID:17602206 copper atom multiple interactions ISO RGD:68562 6480464 [NSC 689534 binds to Copper] which results in decreased expression of SLC7A2 mRNA CTD PMID:20971185 copper(0) multiple interactions ISO RGD:68562 6480464 [NSC 689534 binds to Copper] which results in decreased expression of SLC7A2 mRNA CTD PMID:20971185 copper(II) sulfate decreases expression ISO RGD:68563 6480464 Copper Sulfate results in decreased expression of SLC7A2 mRNA CTD PMID:18579281 crocidolite asbestos affects expression ISO RGD:68562 6480464 Asbestos, Crocidolite affects the expression of SLC7A2 mRNA CTD PMID:24160326 , PMID:25757056 cyclosporin A increases expression ISO RGD:68562 6480464 Cyclosporine results in increased expression of SLC7A2 mRNA CTD PMID:20106945 , PMID:27989131 cyclosporin A affects expression ISO RGD:68562 6480464 Cyclosporine affects the expression of SLC7A2 mRNA CTD PMID:25562108 cyclosporin A decreases expression ISO RGD:68563 6480464 Cyclosporine results in decreased expression of SLC7A2 mRNA CTD PMID:19770486 cytarabine decreases expression ISO RGD:68562 6480464 Cytarabine results in decreased expression of SLC7A2 mRNA CTD PMID:21198554 dieldrin decreases expression EXP 6480464 Dieldrin results in decreased expression of SLC7A2 mRNA CTD PMID:23153324 dorsomorphin multiple interactions ISO RGD:68562 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of SLC7A2 mRNA CTD PMID:29391264 epoxiconazole decreases expression ISO RGD:68563 6480464 epoxiconazole results in decreased expression of SLC7A2 mRNA CTD PMID:35436446 ethanol increases expression ISO RGD:68563 6480464 Ethanol results in increased expression of SLC7A2 mRNA CTD PMID:30319688 flavonoids decreases expression EXP 6480464 Flavonoids results in decreased expression of SLC7A2 mRNA CTD PMID:18035473 folic acid multiple interactions ISO RGD:68563 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of SLC7A2 mRNA CTD PMID:20938992 furan increases methylation EXP 6480464 furan results in increased methylation of SLC7A2 gene CTD PMID:22079235 gamma-hexachlorocyclohexane increases expression EXP 6480464 Hexachlorocyclohexane results in increased expression of SLC7A2 mRNA CTD PMID:17785943 genistein increases expression ISO RGD:68563 6480464 Genistein results in increased expression of SLC7A2 mRNA CTD PMID:32186404 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of SLC7A2 mRNA CTD PMID:33387578 heptachlor decreases expression EXP 6480464 Heptachlor results in decreased expression of SLC7A2 mRNA CTD PMID:23153324 inulin multiple interactions ISO RGD:68563 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of SLC7A2 mRNA CTD PMID:36331819 L-methionine multiple interactions ISO RGD:68563 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of SLC7A2 mRNA CTD PMID:20938992 leflunomide increases expression ISO RGD:68562 6480464 leflunomide results in increased expression of SLC7A2 mRNA CTD PMID:28988120 lipopolysaccharide increases expression ISO RGD:68563 6480464 Lipopolysaccharides results in increased expression of SLC7A2 mRNA CTD PMID:23415871 lipopolysaccharide increases expression ISO RGD:68562 6480464 Lipopolysaccharides results in increased expression of SLC7A2 mRNA CTD PMID:35811015 lipopolysaccharide multiple interactions ISO RGD:68562 6480464 S-(1, 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of SLC7A2 mRNA] CTD PMID:35811015 medroxyprogesterone acetate increases expression ISO RGD:68562 6480464 Medroxyprogesterone Acetate results in increased expression of SLC7A2 mRNA CTD PMID:20843944 mercury atom decreases expression ISO RGD:68562 6480464 Mercury results in decreased expression of SLC7A2 mRNA CTD PMID:19937285 mercury dibromide increases expression ISO RGD:68562 6480464 mercuric bromide results in increased expression of SLC7A2 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:68562 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC7A2 mRNA CTD PMID:27188386 mercury(0) decreases expression ISO RGD:68562 6480464 Mercury results in decreased expression of SLC7A2 mRNA CTD PMID:19937285 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of SLC7A2 mRNA CTD PMID:30467583 methylmercury chloride decreases expression ISO RGD:68562 6480464 methylmercuric chloride results in decreased expression of SLC7A2 mRNA CTD PMID:23179753 mirex decreases expression EXP 6480464 Mirex results in decreased expression of SLC7A2 mRNA CTD PMID:23153324 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of SLC7A2 mRNA CTD PMID:17602206 nickel dichloride increases expression ISO RGD:68562 6480464 nickel chloride results in increased expression of SLC7A2 mRNA CTD PMID:17312168 ozone multiple interactions ISO RGD:68562 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of SLC7A2 mRNA more ... CTD PMID:32699268 paracetamol multiple interactions ISO RGD:68563 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of SLC7A2 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of SLC7A2 mRNA] CTD PMID:17585979 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of SLC7A2 mRNA CTD PMID:33387578 paracetamol affects expression ISO RGD:68562 6480464 Acetaminophen affects the expression of SLC7A2 mRNA CTD PMID:21420995 parathion increases expression ISO RGD:68563 6480464 Parathion results in increased expression of SLC7A2 mRNA CTD PMID:34813904 perfluorononanoic acid increases expression ISO RGD:68562 6480464 perfluoro-n-nonanoic acid results in increased expression of SLC7A2 mRNA CTD PMID:32588087 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:68563 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SLC7A2 mRNA, [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of SLC7A2 mRNA CTD PMID:36331819 phenobarbital multiple interactions ISO RGD:68563 6480464 NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of SLC7A2 mRNA] CTD PMID:19482888 phenobarbital decreases expression ISO RGD:68563 6480464 Phenobarbital results in decreased expression of SLC7A2 mRNA CTD PMID:19482888 , PMID:23091169 phenobarbital increases expression ISO RGD:68563 6480464 Phenobarbital results in increased expression of SLC7A2 mRNA CTD PMID:19270015 phenylmercury acetate increases expression ISO RGD:68562 6480464 Phenylmercuric Acetate results in increased expression of SLC7A2 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:68562 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC7A2 mRNA CTD PMID:27188386 picene decreases expression ISO RGD:68562 6480464 picene results in decreased expression of SLC7A2 mRNA CTD PMID:32251684 pirinixic acid multiple interactions ISO RGD:68563 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of SLC7A2 mRNA CTD PMID:19710929 pirinixic acid increases expression ISO RGD:68563 6480464 pirinixic acid results in increased expression of SLC7A2 mRNA CTD PMID:18445702 progesterone multiple interactions ISO RGD:68562 6480464 [Progesterone co-treated with Estradiol] results in increased expression of SLC7A2 mRNA CTD PMID:17404688 propiconazole decreases expression ISO RGD:68563 6480464 propiconazole results in decreased expression of SLC7A2 mRNA CTD PMID:21278054 resveratrol multiple interactions ISO RGD:68563 6480464 Resveratrol inhibits the reaction [titanium dioxide results in decreased expression of SLC7A2 mRNA] CTD PMID:31298478 rotenone increases expression EXP 6480464 Rotenone results in increased expression of SLC7A2 mRNA CTD PMID:28374803 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:68562 6480464 S-(1, 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of SLC7A2 mRNA] CTD PMID:35811015 SB 431542 multiple interactions ISO RGD:68562 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 serpentine asbestos affects expression ISO RGD:68562 6480464 Asbestos, Serpentine affects the expression of SLC7A2 mRNA CTD PMID:24160326 sevoflurane affects expression EXP 6480464 sevoflurane affects the expression of SLC7A2 mRNA CTD PMID:15967596 silver atom decreases expression ISO RGD:68563 6480464 Silver results in decreased expression of SLC7A2 mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:68563 6480464 Silver results in decreased expression of SLC7A2 mRNA CTD PMID:27131904 sodium arsenite multiple interactions ISO RGD:68563 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SLC7A2 mRNA CTD PMID:32045263 sunitinib increases expression ISO RGD:68562 6480464 Sunitinib results in increased expression of SLC7A2 mRNA CTD PMID:31533062 T-2 toxin decreases expression ISO RGD:68562 6480464 T-2 Toxin results in decreased expression of SLC7A2 mRNA CTD PMID:31863870 testosterone multiple interactions ISO RGD:68562 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of SLC7A2 mRNA CTD PMID:21592394 testosterone decreases expression ISO RGD:68563 6480464 Testosterone results in decreased expression of SLC7A2 mRNA CTD PMID:20403060 , PMID:21669218 testosterone decreases expression ISO RGD:68562 6480464 Testosterone results in decreased expression of SLC7A2 mRNA CTD PMID:21592394 tetrachloromethane decreases expression ISO RGD:68563 6480464 Carbon Tetrachloride results in decreased expression of SLC7A2 mRNA CTD PMID:31919559 titanium dioxide decreases expression ISO RGD:68563 6480464 titanium dioxide results in decreased expression of SLC7A2 mRNA CTD PMID:31298478 titanium dioxide multiple interactions ISO RGD:68563 6480464 Resveratrol inhibits the reaction [titanium dioxide results in decreased expression of SLC7A2 mRNA] CTD PMID:31298478 trichostatin A increases expression ISO RGD:68562 6480464 trichostatin A results in increased expression of SLC7A2 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:68562 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC7A2 mRNA CTD PMID:27188386 Triptolide decreases expression ISO RGD:68563 6480464 triptolide results in decreased expression of SLC7A2 mRNA CTD PMID:32835833 troglitazone decreases expression ISO RGD:68563 6480464 troglitazone results in decreased expression of SLC7A2 mRNA CTD PMID:28973697 trovafloxacin multiple interactions ISO RGD:68563 6480464 [trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of SLC7A2 mRNA CTD PMID:18930950 valproic acid affects expression ISO RGD:68563 6480464 Valproic Acid affects the expression of SLC7A2 mRNA CTD PMID:17963808 valproic acid multiple interactions ISO RGD:68562 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC7A2 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:68562 6480464 Valproic Acid results in increased expression of SLC7A2 mRNA CTD PMID:23179753 more ... valproic acid decreases methylation ISO RGD:68562 6480464 Valproic Acid results in decreased methylation of SLC7A2 gene CTD PMID:29154799 zidovudine decreases expression ISO RGD:68562 6480464 Zidovudine results in decreased expression of SLC7A2 mRNA CTD PMID:24292225 zoledronic acid decreases expression ISO RGD:68562 6480464 zoledronic acid results in decreased expression of SLC7A2 mRNA CTD PMID:24714768